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The good news first: The *Journal of Cachexia, Sarcopenia and Muscle* (*JCSM*), now published in its 10th year, has nearly maintained last year\'s impact factor, even though it has decreased slightly, now reaching 10.754 as published by Thomson Scientific a few weeks ago. The impact factor is calculating from citations to the items in 2016 and 2017 divided by the number of items published in 2016 and 2017. It is important to understand that only the last full years count towards the impact factors, and this is why a journal that has been launched only 12 or 18 months ago can never have an impact factor even though some do calculate their 'unofficial impact factor', which should not be taken too seriously. In addition, it is important to note that the impact factor published in 2019 is the official 2018 impact factor, looked at and calculated using the citations and items published in the previous 2 years. So, at the time of this writing in July 2019, there is no 2019 impact factor, because this will only be published in 2020, usually in June. With regard to our own journal, we had total of 603 citations in 2016 and 838 in 2017. So that in total, 1441 citations were divided by 134 items published in these 2 years resulting in the calculated impact factor of 10.754.[1](#jcsm12482-bib-0001){ref-type="ref"} Fortunately, this places *JCSM* as the number 9 ranked journal among all journals in 'Medicine: General and Internal' (*Table* [1](#jcsm12482-tbl-0001){ref-type="table"}) and as the number 2 ranking journal among all nutrition journals, among which, however, *JCSM* is still not officially listed by Thomson Scientific. However, *JCSM* is listed in the category 'Gerontology', and it still reaches the top position there (*Table* [2](#jcsm12482-tbl-0002){ref-type="table"}).

###### 

Top 10 journals in the field 'Medicine: General and Internal'

                                                             Journal name                                                         Impact factor 2018   Items published 2016 and 2017   Issues per year
  ---- ------------------------------------------------------------------------------------------------------------------------- -------------------- ------------------------------- -----------------
  1     [New England Journal of Medicine](http://admin-apps.webofknowledge.com/JCR/JCR?RQ=RECORD&rank=1&journal=NEW+ENGL+J+MED)         70.670                      655                      52
  2                     [Lancet](http://admin-apps.webofknowledge.com/JCR/JCR?RQ=RECORD&rank=2&journal=LANCET)                          59.102                      639                      52
  3                                     *Journal of the American Medical Association* (*JAMA*)                                          51.273                      421                      48
  4                                                *Nature Reviews Disease Primers*                                                     32.274                      95                        0
  5                                                    *British Medical Journal*                                                        27.604                      361                      52
  6                                                    *JAMA Internal Medicine*                                                         20.768                      267                      12
  7                                                  *Annals of Internal Medicine*                                                      19.315                      279                      24
  8                                                         *PLOS Medicine*                                                             11.048                      393                      12
  9                                          *Journal of Cachexia, Sarcopenia and Muscle*                                               10.754                      134                       4
  10                                                        *BMC Medicine*                                                              8.285                       355                       0

###### 

Top Ten Journals in the field "Geriatrics" where the Journal of Cachexia, Sarcopenia and Muscle is officially listed.

       Journal name                                                                  Impact factor 2018   Items published 2016 and 2017   Issues per year
  ---- ----------------------------------------------------------------------------- -------------------- ------------------------------- -----------------
  1    *Journal of Cachexia Sarcopenia and Muscle*                                   10.754               134                             4
  2    *Ageing Research Reviews*                                                     10.390               172                             4
  3    *Aging Cell*                                                                  7.346                243                             6
  4    *GeroScience*                                                                 6.444                45                              6
  5    *Aging‐US*                                                                    5.515                363                             12
  6    *Journal of the American Medical Directors Association*                       4.899                414                             9
  7    *Journals of Gerontology Series A‐Biological Sciences and Medical Sciences*   4.711                470                             12
  8    *Age*                                                                         4.648                88                              6
  9    *Age and Ageing*                                                              4.511                280                             6
  10   *Neurobiology of Aging*                                                       4.398                618                             6

As before, we would like to sincerely thank all authors, reviewers, and editorial board members for their great efforts to make *JCSM* such a high‐quality and high‐ranked journal, and we greatly appreciate and value the interest and support of all those who enjoy reading *JCSM* and citing the papers published there.

This year is unique for *JCSM* in several ways. The most important is the transfer of the two daughter journals of *JCSM* to Wiley as a publishing house. Indeed, *JCSM* appears to have sparked more scientific interest in the field of body wasting, cachexia, and sarcopenia, and thus, the number of submissions to the main journal remains on the increase. With a 73% rejection rate---knowing that we have to decline publication of many good papers simply for lack of space---we hope to be able to give some of these a home in our two daughter journals---*JCSM Rapid Communications* and *JCSM Clinical Reports*. *JCSM Clinical Reports* is online since December 2016 and *JCSM Rapid Communications* since January 2018. The first is dedicated to publishing clinical studies from the area of cachexia, wasting, and muscle disorders, and the second aims to publish both clinical and basic research papers with high relevance to the audience in this still niche area. We hope that the three journals will help in clinical decision making and in serving as a source of clinical information and case reports as well.

The main journal, *JCSM*, has, at the time of this writing, received 294 submissions in 2019 alone. Last year at this time, we had received 209. We are working hard to provide a timely peer review, which is not always easy, as it is difficult at times to find appropriate reviewers. Articles that are available for the longest time are---not surprisingly---those that have been cited the most (*Table* [3](#jcsm12482-tbl-0003){ref-type="table"}). Our editorials remain popular (*Table* [4](#jcsm12482-tbl-0004){ref-type="table"}), and we invite our readers to submit their work or to suggest topics for 'facts and numbers' editorials that are relevant to our readers.

###### 

Top 30 of best cited articles since first publication of the Journal of Cachexia, Sarcopenia and Muscle

  Rank   First author   Title                                                                                                                                                                                                                               Type               Year   Times cited                    Reference
  ------ -------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------ ------ ------------- -------------------------------------------
  1      von Haehling   Cachexia as a major underestimated and unmet medical need: facts and numbers                                                                                                                                                        Editorial          2010   385            [2](#jcsm12482-bib-0002){ref-type="ref"}
  2      Dalton         The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial           Original article   2011   154            [3](#jcsm12482-bib-0003){ref-type="ref"}
  3      Morley         Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology---update 2014                                                                                                                            Editorial          2014   144            [4](#jcsm12482-bib-0004){ref-type="ref"}
  4      Fanzani        Molecular and cellular mechanisms of skeletal muscle atrophy: an update                                                                                                                                                             Review             2012   121            [5](#jcsm12482-bib-0005){ref-type="ref"}
  5      Lenk           Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training                                                                                                                       Review             2010   117            [6](#jcsm12482-bib-0006){ref-type="ref"}
  6      Wakabayashi    Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management                                                                                                         Review             2014   115            [7](#jcsm12482-bib-0007){ref-type="ref"}
  7      Cesari         Biomarkers of sarcopenia in clinical trials---recommendations from the International Working Group on Sarcopenia                                                                                                                    Original article   2012   115            [8](#jcsm12482-bib-0008){ref-type="ref"}
  8      Morley         From sarcopenia to frailty: a road less traveled                                                                                                                                                                                    Editorial          2014   114            [9](#jcsm12482-bib-0009){ref-type="ref"}
  9      Elkina         The role of myostatin in muscle wasting: an overview                                                                                                                                                                                Review             2011   111            [10](#jcsm12482-bib-0010){ref-type="ref"}
  10     von Haehling   An overview of sarcopenia: facts and numbers on prevalence and clinical impact                                                                                                                                                      Editorial          2010   111            [11](#jcsm12482-bib-0011){ref-type="ref"}
  11     Mak            Wasting in chronic kidney disease                                                                                                                                                                                                   Review             2011   105            [12](#jcsm12482-bib-0012){ref-type="ref"}
  12     von Haehling   Prevalence, incidence and clinical impact of cachexia: facts and numbers---update 2014                                                                                                                                              Editorial          2014   104            [13](#jcsm12482-bib-0013){ref-type="ref"}
  13     Patel          Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross‐sectional study and review of literature                                                                                                  Review             2013   103            [14](#jcsm12482-bib-0014){ref-type="ref"}
  14     Malstrom       SARC‐F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes                                                                                                                                     Original article   2016   101            [15](#jcsm12482-bib-0015){ref-type="ref"}
  15     Dasarathy      Consilience in sarcopenia of cirrhosis                                                                                                                                                                                              Review             2012   93             [16](#jcsm12482-bib-0016){ref-type="ref"}
  16     Bowen          Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training                                                                                                                       Review             2015   92             [17](#jcsm12482-bib-0017){ref-type="ref"}
  17     Vaughan        Cancer cachexia: impact, mechanisms and emerging treatments                                                                                                                                                                         Review             2013   82             [18](#jcsm12482-bib-0018){ref-type="ref"}
  18     von Haehling   From muscle wasting to sarcopenia and myopenia: update 2012                                                                                                                                                                         Editorial          2012   80             [19](#jcsm12482-bib-0019){ref-type="ref"}
  19     Lainscak       The obesity paradox in chronic disease: facts and numbers                                                                                                                                                                           Editorial          2012   80             [20](#jcsm12482-bib-0020){ref-type="ref"}
  20     Lainscak       Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease                                                                                                             Original article   2011   79             [21](#jcsm12482-bib-0021){ref-type="ref"}
  21     Fearon         Myopenia---a new universal term for muscle wasting                                                                                                                                                                                  Editorial          2011   73             [22](#jcsm12482-bib-0022){ref-type="ref"}
  22     Montano‐Loza   Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis                                                                                                                                 Original article   2016   72             [23](#jcsm12482-bib-0023){ref-type="ref"}
  23     Calvani        Biomarkers for physical frailty and sarcopenia: state of the science and future developments                                                                                                                                        Review             2015   72             [24](#jcsm12482-bib-0024){ref-type="ref"}
  24     Rozentryt      The effects of a high‐caloric protein‐rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double‐blind pilot study   Original article   2010   70             [25](#jcsm12482-bib-0025){ref-type="ref"}
  25     Schefold       Intensive care unit‐acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock                                                                                                     Review             2010   69             [26](#jcsm12482-bib-0026){ref-type="ref"}
  26     Chen           Ghrelin prevents tumour‐ and cisplatin‐induced muscle wasting: characterization of multiple mechanisms involved                                                                                                                     Original article   2015   68             [27](#jcsm12482-bib-0027){ref-type="ref"}
  27     Anker          Welcome to the ICD‐10 code for sarcopenia                                                                                                                                                                                           Editorial          2016   65             [28](#jcsm12482-bib-0028){ref-type="ref"}
  28     Hexmsfield     Assessing skeletal muscle mass: historical overview and state of the art                                                                                                                                                            Review             2014   65             [29](#jcsm12482-bib-0029){ref-type="ref"}
  29     Farkas         Cachexia as a major public health problem: frequent, costly, and deadly                                                                                                                                                             Review             2013   64             [30](#jcsm12482-bib-0030){ref-type="ref"}
  30     Santarpia      Butyrylcholinesterase as a prognostic marker: a review of the literature                                                                                                                                                            Review             2013   64             [31](#jcsm12482-bib-0031){ref-type="ref"}

###### 

Top 30 articles published in 2016/17 sorted by citations in 2018. Of note, these 30 papers contributed 36% of citations for our impact factor 2018

  Rank   First author               Title                                                                                                                                                                                                                                                 Type               Year   Times cited                    Reference
  ------ -------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------ ------ ------------- -------------------------------------------
  1      Malmstrom, Theodore K.     SARC‐F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes                                                                                                                                                       Original article   2016   36             [15](#jcsm12482-bib-0015){ref-type="ref"}
  2      Montano‐Loza, Aldo J.      Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis                                                                                                                                                   Original article   2016   29             [23](#jcsm12482-bib-0023){ref-type="ref"}
  3      Rutten, Iris J. G.         Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients                                                                                                                                   Original article   2016   27             [32](#jcsm12482-bib-0032){ref-type="ref"}
  4      van Dijk, David P. J.      Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer                                                                                 Original article   2017   24             [33](#jcsm12482-bib-0033){ref-type="ref"}
  5      Tyrovolas, Stefanos        Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi‐continent study                                                                                                                             Original article   2016   22             [34](#jcsm12482-bib-0034){ref-type="ref"}
  6      Kalafateli, Maria          Malnutrition and sarcopenia predict post‐liver transplantation outcomes independently of the Model for End‐stage Liver Disease score                                                                                                                  Original article   2017   21             [35](#jcsm12482-bib-0035){ref-type="ref"}
  7      Boengler, Kerstin          Mitochondria and ageing: role in heart, skeletal muscle and adipose tissue                                                                                                                                                                            Review             2017   21             [36](#jcsm12482-bib-0036){ref-type="ref"}
  8      Brown, Justin C.           Sarcopenia and mortality among a population‐based sample of community‐dwelling older adults                                                                                                                                                           Original article   2016   20             [37](#jcsm12482-bib-0037){ref-type="ref"}
  9      Solheim, Tora S.           A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer                                                                                                                     Original article   2017   19             [38](#jcsm12482-bib-0038){ref-type="ref"}
  10     Loncar, Goran              Cardiac cachexia: hic et nunc                                                                                                                                                                                                                         Review             2016   18             [39](#jcsm12482-bib-0039){ref-type="ref"}
  11     Nijholt, Willemke          The reliability and validity of ultrasound to quantify muscles in older adults: a systematic review                                                                                                                                                   Review             2017   17             [40](#jcsm12482-bib-0040){ref-type="ref"}
  12     Mochamat, Henning C.       A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project                                                           Review             2017   17             [41](#jcsm12482-bib-0041){ref-type="ref"}
  13     Rutten, Iris J. G.         Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer                                                                                                                               Original article   2017   17             [42](#jcsm12482-bib-0042){ref-type="ref"}
  14     Leong, Darryl P.           Reference ranges of handgrip strength from 125,462 healthy adults in 21 countries: a prospective urban rural epidemiologic (PURE) study                                                                                                               Original article   2016   16             [43](#jcsm12482-bib-0043){ref-type="ref"}
  15     Holecek, Milan             Beta‐hydroxy‐beta‐methylbutyrate supplementation and skeletal muscle in healthy and muscle‐wasting conditions                                                                                                                                         Review             2017   16             [44](#jcsm12482-bib-0044){ref-type="ref"}
  16     Sanders, Karin J. C.       Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective                                                                                                                                                           Review             2016   15             [45](#jcsm12482-bib-0045){ref-type="ref"}
  17     Reijnierse, Esmee M.       Assessment of maximal handgrip strength: how many attempts are needed?                                                                                                                                                                                Original article   2017   15             [46](#jcsm12482-bib-0046){ref-type="ref"}
  18     Stewart Coats, Andrew J.   Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non‐small cell lung cancer or colorectal cancer: a randomized, double‐blind, placebo‐controlled, international multicentre phase II study (the ACT‐ONE trial)   Original article   2016   14             [47](#jcsm12482-bib-0047){ref-type="ref"}
  19     Kittiskulnam, Piyawan      Sarcopenia among patients receiving hemodialysis: weighing the evidence                                                                                                                                                                               Original article   2017   14             [48](#jcsm12482-bib-0048){ref-type="ref"}
  20     Snijders, Tim              Muscle fibre capillarization is a critical factor in muscle fibre hypertrophy during resistance exercise training in older men                                                                                                                        Original article   2017   14             [49](#jcsm12482-bib-0049){ref-type="ref"}
  21     Foong, Yi Chao             Accelerometer‐determined physical activity, muscle mass, and leg strength in community‐dwelling older adults                                                                                                                                          Original article   2016   13             [50](#jcsm12482-bib-0050){ref-type="ref"}
  22     Nishikawa, Hiroki          Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis                                                                                                                                                     Original article   2017   13             [51](#jcsm12482-bib-0051){ref-type="ref"}
  23     Martone, Anna Maria        The incidence of sarcopenia among hospitalized older patients: results from the Glisten study                                                                                                                                                         Original article   2017   13             [52](#jcsm12482-bib-0052){ref-type="ref"}
  24     van de Bool, Coby          A randomized clinical trial investigating the efficacy of targeted nutrition as adjunct to exercise training in COPD                                                                                                                                  Original article   2017   13             [53](#jcsm12482-bib-0053){ref-type="ref"}
  25     Clark, Andrew L.           Effect of beta‐adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial                                                                                                                     Original article   2017   13             [54](#jcsm12482-bib-0054){ref-type="ref"}
  26     van Vugt, Jeroen L. A.     A comparative study of software programmes for cross‐sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients                                                                       Original article   2017   13             [55](#jcsm12482-bib-0055){ref-type="ref"}
  27     Beaudart, Charlotte        Validation of the SarQoL^®^, a specific health‐related quality of life questionnaire for sarcopenia                                                                                                                                                   Original article   2017   13             [56](#jcsm12482-bib-0056){ref-type="ref"}
  28     Barbosa‐Silva, Thiago G.   Prevalence of sarcopenia among community‐dwelling elderly of a medium‐sized South American city: results of the *COMO VAI?* study                                                                                                                     Original article   2016   13             [57](#jcsm12482-bib-0057){ref-type="ref"}
  29     Batista, Miguel L., Jr.    Cachexia‐associated adipose tissue morphological rearrangement in gastrointestinal cancer patients                                                                                                                                                    Original article   2016   13             [58](#jcsm12482-bib-0058){ref-type="ref"}
  30     Nederveen, Joshua P.       Skeletal muscle satellite cells are located at a closer proximity to capillaries in healthy young compared with older men                                                                                                                             Original article   2016   13             [59](#jcsm12482-bib-0059){ref-type="ref"}

Finally, we would like to draw your attention to the upcoming Cachexia Conference, to be held between December 6 and 8, 2019, in Berlin, Germany. The conference became an annual meeting, and it is a source of stimulating ideas and exchange between clinicians and researchers in the field of cachexia and wasting. More information can be found at the following link: [http://society‐scwd.org](http://society-scwd.org).
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